Skip to content
★ Sign in to follow
Bharat Parenterals logo

Bharat Parenterals Stock: price and insider trades · India

IN·Mcap ₹13B

No insider purchase over the last 90 days. The latest, by Desai Shares & Stock Pvt Ltd, was filed 16 Jul 2026.

Bharat Parenterals: what insiders have been doing

Bharat Parenterals is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). Over the twelve months to 10 November 2026, 4 filings were filed, from 4 insiders.

No insider sold shares on the market over the period. Instead, the filings list 4 purchases totalling €11k, made by 4 insiders. The amount is not disclosed for 3 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €11k, bought by Desai Shares and Stock Private Limited and made public on 16 June 2026. Those buying include 3 major shareholders.

Across the 1,985 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark. Looking back to 2026, when coverage begins, insiders filed 4 purchases and no sales.

The last purchase on record was published on 16 July 2026, which is 117 days ago. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. Until a filing is published, the market cannot know about the trade.

This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Insider Decl.
4
Thresholds
n/a
Buy Volume
€11,496
4 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Desai Shares & Stock Pvt Ltd1 buy
Desai Shares & Stocks Pvt Ltd1 buy
Desai Shares and Stock Private Limited1 buy
Desai Shares and Stock Pvt Ltd1 buy

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 22,932 of 26,911 companies
26.4
score / 100
Value
22
Quality
30
FCF yld-0.1%
Earn yld-0.6%
EV/EBITDA57.9x
ROE-3.0%
Gross mgn40%
Net mgn-2.4%
Debt/EBITDA6.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹1,890.85
Analyst consensus
·
Income statement
Revenue₹3.4B
Gross profit₹1.4B40% margin
EBITDA₹242.9M7% margin
Net income-₹81.9M-4.8% margin
Valuation
P/Book2.4x
Beta0.72
Balance sheet & cash
Market cap₹13B
Total debt₹1.5B
Free Cash Flow-₹15.7M
Debt / Equity47%
Profitability & ownership
ROE-8.4%
ROA-1.8%
% insiders79.7%
% institutions0.0%
Last declaration on 16 July 2026
Declarations4 total
  • ▲
    Related company / holdingExecutives
    0SEBI
    1,356 shares-MarketSEBI:960064c90f80a6d9dbe40a3857de9c4cffd4be19
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    0SEBI
    1,356 shares-MarketSEBI:8dd393fe2f0b6b54527f221c8c03cd211f122dcc
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    0SEBI
    900 shares-MarketSEBI:6a4714ee8cc27d6a024e3f5753083880924e8c1a
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    1M INR13SEBI
    900 shares@ ₹1,402.40100.0% of flowEquity SharesMarket PurchaseSEBI:6fc2971780f9cdbe205c47393ebbeaecb1e2d05a
    Canonical exit: 14 Sept 2026 (T+90)

4 of 4 declarations

About Bharat Parenterals

Bharat Parenterals is a company specializing in the manufacture of injectable pharmaceutical products. It is listed on the XBOM market.